2025 marked a breakthrough year for MeCure Industries Plc.
The company delivered a pre-tax profit of ₦7.93 billion, climbing 140% from ₦3.30 billion in 2024.
MeCure Record Profit Surge
Moreover, profit after tax soared 177.5% to ₦6.46 billion, achieving the highest three-year earnings in the company’s history.
Revenue grew sharply to ₦77.69 billion, up 68.8% from the previous year, as strong demand drove its pharmaceutical manufacturing and distribution operations.
Acute And OTC Lead Growth
In particular, the Acute and OTC product lines led the growth.
Acute products generated ₦42 billion, rising 69%, while OTC products contributed ₦17.3 billion, up 68.8%.
Together, these two segments accounted for approximately 77% of total revenue, highlighting the company’s strategic focus on its key growth areas.
Read Also; FAAN Bans Cash At Airports, Parking, Lounges From March 1
As a result, gross profit climbed 79.3% to ₦26.51 billion, demonstrating improved scale and cost absorption despite rising input costs.
Consequently, operating profit nearly doubled to ₦16.43 billion, reflecting operational efficiency as expenses grew slower than revenue.
However, finance costs increased to ₦8.49 billion due to higher borrowings.
Total external debt rose to ₦55.33 billion, driven by commercial paper and working capital facilities.
Nonetheless, operating profit covered finance costs twice over, up from 1.6 times in 2024, signalling stronger efficiency and resilience.
Strong Balance Sheet and Shareholder Returns
Total assets grew 49.45% to ₦81.96 billion, boosted by property, plant, inventories and receivables.
Meanwhile, cash balances improved to ₦6.48 billion, and equity rose 41.98% to ₦19.82 billion.
Earnings per share jumped 179.31% to ₦1.62, and the Board proposed a dividend of ₦0.32 per share, more than double last year’s payout.
Finally, the share price rose from ₦65.20 to ₦75.85, a 16.3% gain year-to-date, reflecting strong investor confidence.
Overall, MeCure’s 2025 journey combined strategic growth, operational discipline and rising market demand to deliver record profits.
